Oral JAK1 Inhibitor Shows Promise for Hidradenitis Suppurativa Oral JAK1 Inhibitor Shows Promise for Hidradenitis Suppurativa

The investigational oral small molecule, known for now as INCB54707, is 52 times more selective for JAK1 than JAK2.Medscape Medical News
Source: Medscape Dermatology Headlines - Category: Dermatology Tags: Dermatology News Source Type: news